Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 2006Current Opinion in Lipidology

Glycated hemoglobin as a marker of cardiovascular risk

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKay‐Tee KhawNWNicholas J. Wareham

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khaw et al. (2006) studied this question.

synapsesocial.com/papers/6a87a7a6730e3a19d7792ab7https://doi.org/10.1097/mol.0b013e3280106b95
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction1998 · 7,098 citations
  2. 2Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study1979 · 1,208 citations
  3. 3Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial1993 · 4,104 citations
  4. 4Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes1994 · 489 citations
  5. 5Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation1998 · 15,325 citations